For the quarter ending 2025-11-30, CNBX has $11,162 in assets. $7,703 in cash and cash equivalents.
| Balance Sheets | 2025-11-30 | 2025-08-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,703 | 15,111 | ||
| Prepaid expenses and other receivables | 3,459 | 3,326 | ||
| Total current assets | 11,162 | 18,437 | ||
| Equipment, net | 0 | 0 | ||
| Total assets | 11,162 | 18,437 | ||
| Accounts payable and accrued liabilities | 45,631 | 49,252 | ||
| Convertible loan | 1,206,512 | 1,197,257 | ||
| Short term loan | 40,000 | - | ||
| Due to a related party | 1,291,990 | 1,268,221 | ||
| Total current liabilities | 2,584,133 | 2,514,730 | ||
| Common stock, 0.0001 par value, 1,800,000,000 shares authorized on november 30, 2025 and august 31, 2025 respectively. 753,196,666 and 553,962,206 shares issued and outstanding on november 30, 2025 and august 31, 2025 respectively | 75,319 | 55,396 | ||
| Additional paid-in capital | 22,733,805 | 22,716,687 | ||
| Accumulated deficit | -25,382,095 | -25,268,376 | ||
| Total stockholders' equity (deficit) | -2,572,971 | -2,496,293 | ||
| Total liabilities and stockholders' equity | 11,162 | 18,437 | ||
CNBX Pharmaceuticals Inc. (CNBX)
CNBX Pharmaceuticals Inc. (CNBX)